The impact of genetics on future drug discovery in schizophrenia
Year: 2017
Type: review
Source: Expert Opinion on Drug Discovery
Authors: Mitsuyuki Matsumoto, Noah M. Walton, Hiroshi Yamada, Yuji Kondo, Gerard J. Marek, Katsunori Tajinda
Institutions: Astellas Pharma (Japan), Astellas Pharma (United States)
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2615474375